SLC5A2 and liver dysplastic nodule: A multidisciplinary therapeutic strategy is generally employed for DN, including stringent glucose control, blood pressure control with renin-angiotensin system (RAS) inhibitors, and the use of sodium-glucose co-transporter 2 (SGLT2) inhibitors.